| 2010 |
MICU1 is a mitochondrial inner membrane-associated protein with two canonical EF-hand domains that is required for mitochondrial Ca2+ uptake; RNAi silencing abolishes mitochondrial Ca2+ entry in intact and permeabilized cells without disrupting respiration or membrane potential, and EF-hand mutations abolish its activity, indicating a Ca2+-sensing role. |
RNAi knockdown, mitochondrial Ca2+ measurement, EF-hand mutagenesis, subcellular fractionation |
Nature |
High |
20693986
|
| 2012 |
MICU1 interacts with the pore-forming MCU subunit and acts as a gatekeeper that sets a Ca2+ threshold for mitochondrial Ca2+ uptake; loss of MICU1 causes constitutive mitochondrial Ca2+ loading, excessive ROS generation, and increased apoptotic sensitivity, without altering MCU kinetic properties. |
Co-immunoprecipitation, RNAi knockdown, mitochondrial Ca2+ measurement, ROS assay, apoptosis assay |
Cell |
High |
23101630
|
| 2013 |
MICU1 faces the intermembrane space and controls both the threshold and cooperative (sigmoidal) activation of the mitochondrial Ca2+ uniporter; loss of MICU1 in mouse liver and cultured cells causes Ca2+ accumulation at low cytoplasmic [Ca2+] but an attenuated response to agonist-induced Ca2+ pulses, reflecting loss of positive cooperativity mediated by EF-hands. |
In vivo RNAi (mouse liver), live-cell Ca2+ imaging, submitochondrial fractionation/protease protection, genetic knockout |
Cell metabolism |
High |
23747253
|
| 2013 |
MICU1 (CBARA1) and MICU2 reside within the same uniporter complex with MCU; biochemical evidence shows MCU, MICU1, and MICU2 cross-stabilize each other's protein expression in a cell-type-dependent manner, and in vivo silencing of both MICU1 and MICU2 additively impairs Ca2+ handling. |
Co-immunoprecipitation, Western blot, in vivo RNAi (mouse liver), mitochondrial Ca2+ measurement |
PloS one |
High |
23409044
|
| 2013 |
MICU1 localizes to the mitochondrial matrix side of the inner membrane; its N-terminal polybasic domain binds to two coiled-coil domains of MCU, and this interaction is required for MICU1 oligomeric binding to MCU and control of mitochondrial Ca2+ current. MICU1 EF-hands regulate MCU channel activity but do not determine MCU binding. Loss of MICU1 promotes MCU activation, oxidative burden, and halts cell migration. |
Submitochondrial fractionation, domain mutagenesis, Co-IP, Ca2+ current (IMCU) measurement, cell migration assay |
Cell reports |
Medium |
24332854
|
| 2013 |
Loss-of-function mutations in MICU1 in human patients increase agonist-induced mitochondrial Ca2+ uptake at low cytoplasmic [Ca2+], reduce cytoplasmic Ca2+ signals, and cause severe mitochondrial network fragmentation, establishing that MICU1 is required for normal mitochondrial Ca2+ signaling in humans. |
Patient fibroblast analysis, mitochondrial Ca2+ imaging, mitochondrial membrane potential measurement, microscopy |
Nature genetics |
High |
24336167
|
| 2014 |
MICU1 and MICU2 play non-redundant roles: both set the [Ca2+] threshold for uniporter activation. MICU1 or MICU2 KO each eliminate normal Ca2+ uptake threshold. MICU2's activity and physical association with the pore require MICU1 presence, but MICU1 does not require MICU2. EF-hand-dead mutants of either cause striking loss of Ca2+ uptake. |
CRISPR/Cas9 knockout, Ca2+ uptake assay, Co-immunoprecipitation, EF-hand mutagenesis |
EMBO reports |
High |
24503055
|
| 2014 |
In MICU1-knockdown cells, mitochondrial Ca2+ uptake rate is increased at low [Ca2+]c (<2 µM) but decreased at high [Ca2+]c (>4 µM), and Ca2+ uptake becomes subject to a slow-developing inhibition at prolonged low micromolar [Ca2+]c. MICU1 thus acts both as a gatekeeper at low [Ca2+]c and as a cofactor needed to reach maximum uptake rate at high [Ca2+]c. |
shRNA knockdown, real-time mitochondrial Ca2+ measurement with targeted aequorin, Ruthenium Red/Ru360 sensitivity assay |
The Biochemical journal |
Medium |
24313810
|
| 2015 |
The mitochondrial oxidoreductase Mia40/CHCHD4 introduces an intermolecular disulfide bond linking MICU1 and MICU2 in a heterodimer; absence of this disulfide increases mitochondrial Ca2+ uptake. The MICU1-MICU2 heterodimer associates with MCU at low Ca2+ and dissociates at high Ca2+, providing a Ca2+-dependent remodeling mechanism for uniporter regulation. |
Mia40 interactome (MS), disulfide bond analysis, Co-IP, Ca2+ uptake assay, mutagenesis |
Cell metabolism |
High |
26387864
|
| 2015 |
Live-cell FRET experiments show that cytosolic Ca2+ elevation rearranges MICU1 multimers with an EC50 of ~4.4 µM, activating mitochondrial Ca2+ uptake. This rearrangement requires EF-hand motifs and is independent of matrix Ca2+ concentration, mitochondrial membrane potential, and MCU/EMRE expression levels. |
Live-cell FRET, Ca2+ imaging, EF-hand mutagenesis |
Scientific reports |
Medium |
26489515
|
| 2016 |
MICU1 deficiency in mice results in altered mitochondrial Ca2+ uptake, increased resting matrix Ca2+, altered mitochondrial morphology, and reduced ATP early in life. Deleting one allele of EMRE in MICU1-/- mice normalizes Ca2+ uptake and rescues perinatal mortality, establishing EMRE as a downstream effector of MICU1-dependent gating. |
Genetic mouse knockout, EMRE heterozygous cross (epistasis), mitochondrial Ca2+ measurement, ATP assay, electron microscopy |
Cell reports |
High |
27477272
|
| 2016 |
PRMT1 asymmetrically methylates MICU1, decreasing its Ca2+ sensitivity. UCP2/3 normalize Ca2+ sensitivity of methylated MICU1, re-establishing mitochondrial Ca2+ uptake activity. This defines a post-translational modification pathway controlling uniporter activity. |
PRMT1 methylation assay, Ca2+ uptake measurement, UCP2/3 co-expression, mutagenesis |
Nature communications |
Medium |
27642082
|
| 2016 |
MICU1 KO in mice causes perinatally lethal Ca2+ overload-induced mitochondrial permeability transition pore (PTP) opening in hepatocytes; PTP inhibition prevents necrosis and rescues liver regeneration after hepatectomy, establishing that MICU1 gatekeeping of MCU is essential for controlling PTP-dependent cell death under stress. |
Conditional knockout mouse, partial hepatectomy model, PTP inhibitor treatment, mitochondrial Ca2+ measurement, cell death assays |
Nature communications |
High |
26956930
|
| 2017 |
The MICU1:MCU protein stoichiometry directly determines tissue-specific uniporter phenotypes: low MICU1:MCU lowers the Ca2+ threshold and activation cooperativity (as in heart/skeletal muscle); overexpressing MICU1 in heart shifts it to a liver-like phenotype with higher threshold and causes cardiac contractile dysfunction. |
Tissue protein quantification, MICU1 overexpression (adenovirus), Co-IP stoichiometry, mitochondrial Ca2+ uptake, cardiac function measurement |
Cell reports |
High |
28273446
|
| 2017 |
MICU1 silencing in ovarian cancer activates pyruvate dehydrogenase (PDH) by stimulating the PDH phosphatase–phosphoPDH–PDH axis, increasing oxygen consumption and decreasing aerobic glycolysis; forced MICU1 expression in normal cells phenocopies the metabolic shift to glycolysis seen in cancer cells. |
siRNA knockdown, PDH activity assay, oxygen consumption measurement, lactate production assay, xenograft tumor model |
Nature communications |
Medium |
28530221
|
| 2017 |
MICU2 regulates the threshold and gain of MICU1-mediated inhibition and activation of MCU; MICU1 alone can mediate gatekeeping and cooperative activation, while MICU2's fundamental role is to modulate these MICU1 functions, spatially restricting Ca2+ crosstalk between InsP3R and MCU channels. |
Quantitative cytoplasmic Ca2+ clamping with patch clamp, MICU1/MICU2 knockdown, Ca2+ uptake measurement over wide [Ca2+] range |
Cell reports |
Medium |
29241542
|
| 2018 |
Parkin (PARK2) E3 ubiquitin ligase interacts with MICU1 and promotes its selective degradation via the ubiquitin proteasome system (UPS); Parkin's Ubl-domain (not its E3 ligase activity) is required for this degradation, reducing MICU1 basal levels and indirectly affecting MICU2 stability. |
Co-immunoprecipitation, proteasome inhibitor treatment, Parkin domain mutants, Western blot for protein stability |
Scientific reports |
Medium |
30242232
|
| 2018 |
MICU1 suppresses inhibition of MCU by ruthenium red/Ru360 at MCU's DIME motif. A DIME-interacting domain (DID) in MICU1 is identified that is required for both gatekeeping and cooperative activation of MCU and for cell survival, indicating MICU1 must interact with the D-ring formed by MCU's DIME domains to control the uniporter. |
Ru360 inhibition assay, MICU1 DID mutagenesis, Co-IP, mitochondrial Ca2+ uptake measurement, cell survival assay |
Molecular cell |
High |
30454562
|
| 2017 |
Tom70 (mitochondrial import receptor) governs the mitochondrial localization of MICU1; Tom70 deficiency reduces mitochondrial MICU1 levels and worsens Ca2+ overload and myocardial ischemia-reperfusion injury, while MICU1 supplementation rescues Tom70-mediated cardioprotection. |
siRNA knockdown in vivo (intramyocardial injection), Western blot of mitochondrial fractions, Ca2+ measurement, cardiac function assay |
Cell death & disease |
Medium |
28703803
|
| 2019 |
The DIME-aspartate of MCU mediates a Ca2+-modulated electrostatic interaction with MICU1, forming a contact interface with a nearby Ser residue; mutagenesis screen identifies two conserved Arg residues in MICU1 that contact DIME-Asp. Disrupting MCU-MICU1 interactions causes unregulated, constitutive Ca2+ flux into mitochondria. |
Mutagenesis screen, Co-IP, electrophysiology (Ca2+ flux), structural-functional analysis |
eLife |
High |
30638448
|
| 2019 |
Crystal structure of MICU2 at 2.5 Å resolution reveals a core structure similar to MICU1 with two EF-hand lobes; a symmetric homodimer interface (EF1-EF3) is conserved in both MICU1 and MICU2, enabling exchange between homo- and heterodimers. MICU2's C-terminal helix is dispensable for MICU1 interaction in vitro but required for MICU2 function in cells. |
X-ray crystallography, in vitro binding assay, C-terminal deletion mutagenesis, cell-based Ca2+ uptake assay |
PNAS |
High |
30755530
|
| 2019 |
Loss of MICU1 in skeletal muscle (patient cells and muscle-specific KO mice) lowers the MCU-mediated Ca2+ uptake threshold, impairs mitochondrial Ca2+ uptake during excitation-contraction, causes aerobic metabolism impairment, muscle weakness, fatigue, and compromises sarcolemmal repair by reducing mitochondrial Ca2+ uptake at injury sites. |
Skeletal muscle-specific conditional KO, patient cell analysis, Ca2+ imaging, mitochondrial respiration, sarcolemmal repair assay, grip strength |
Cell reports |
High |
31665639
|
| 2020 |
Cryo-EM structure of MCU-EMRE-MICU1-MICU2 holocomplex at 3.3 Å shows that a uniporter interaction domain on MICU1 binds a receptor site on MCU and EMRE subunits (analogous to channel block by protein toxins) to inhibit ion flow at resting Ca2+; Ca2+-bound structure at 3.1 Å shows Ca2+-dependent changes in MICU1-MICU2 enabling dynamic response to cytosolic Ca2+ signals. |
Cryo-EM structure determination (3.3 Å and 3.1 Å), structural comparison of Ca2+-free and Ca2+-bound states |
eLife |
High |
32667285
|
| 2020 |
Inhibition of glycolysis, mitochondrial pyruvate transport (MPC), or mitochondrial fatty acid transport triggers upregulation of MICU1 protein (but not MCU) via the transcription factor EGR1, resulting in inhibition of MCU-mediated matrix Ca2+ uptake; MPC1 genetic ablation reduces resting matrix Ca2+ through this MICU1-dependent mechanism. |
MPC isoform knockdown/KO, dominant-negative MPC1 mutant, MICU1 protein quantification, EGR1 transcription factor assay, mitochondrial Ca2+ measurement |
Science signaling |
Medium |
32317369
|
| 2022 |
Neuron-specific MICU1 KO mice show progressive neurodegeneration with degeneration of motor neurons; MICU1-KO neurons show increased susceptibility to mitochondrial Ca2+ overload-induced excitotoxic cell death, which is prevented by inhibiting the mitochondrial permeability transition pore (mPTP), placing MICU1 upstream of mPTP in neurodegeneration. |
Neuron-specific conditional KO mouse, electrophysiology, Ca2+ imaging, cell death assay, mPTP inhibitor rescue, patient-derived cell analysis |
Science advances |
High |
35302860
|
| 2023 |
MICU1 localizes to the mitochondrial contact site and cristae organizing system (MICOS) and directly interacts with MICOS components MIC60 and CHCHD2 independently of the mtCU complex; MICU1 is essential for MICOS complex formation, and its ablation causes altered cristae organization, mitochondrial ultrastructure, membrane dynamics, and cell death signaling independently of matrix Ca2+ uptake. |
Proteomics (co-fractionation), Co-IP, confocal/EM imaging, MICU1 KO with MICOS component analysis, cell death assay |
Science signaling |
High |
37098122
|
| 2023 |
MICU1 physically occludes the MCU pore: purified MICU1 strongly suppresses MCU Ca2+ currents in patch-clamp; a K126 mutation in MICU1's MCU-interacting residue abolishes inhibition. MICU1 also prevents MCU-mediated Na+ flux into intact mitochondria under Ca2+-free conditions. MICU1 dissociates from the uniporter complex during mitoplast preparation, explaining why prior patch-clamp studies failed to detect pore blockade. |
Patch-clamp of purified MCU, membrane depolarization Na+ flux assay, K126 mutagenesis, EMRE quantification, MICU1 KO rescue |
PNAS |
High |
37036971
|
| 2023 |
MICU1 restricts cation flux through the mtCU in the absence of Ca2+ (divalent-free conditions), as shown by increased Ru265-sensitive Na+ influx in MICU1 KO cells; however, even in WT cells with high MICU1 expression some mtCU lack MICU1-dependent gating, and MICU1 KO causes rearrangement of mtCU and altered number of functional channels. |
Fluorescence-based mitochondrial matrix [Na+] measurement, mitochondrial swelling/depolarization assay, Ru265 inhibitor, MICU1 KO and stable rescue HEK cells |
PNAS |
High |
37126688
|
| 2023 |
MICU1 deficiency alters mitochondrial cristae junction structure (through MICOS interaction with Mic60 and CHCHD2), leading to increased cytochrome c release, mitochondrial membrane potential rearrangement, and altered mitochondrial Ca2+ uptake dynamics. |
MICU1 KO cell analysis, Co-IP (MICU1-Mic60-CHCHD2), cytochrome c release assay, membrane potential measurement, Ca2+ uptake assay |
Cell calcium |
Medium |
37290367
|
| 2018 |
MICU1 deletion sensitizes human cells to manganese-dependent cell death by disinhibiting MCU-mediated manganese uptake, demonstrating that MICU1's gating function controls uniporter selectivity beyond Ca2+; co-expression of MICU1 with MCU and EMRE in yeast prevents manganese stress, while MICU1 deletion worsens it. |
Synthetic biology reconstitution in yeast, MICU1 KO human cells, manganese toxicity assay, oxidative stress measurement, evolutionary co-occurrence analysis |
Cell reports |
Medium |
30403999
|
| 2018 |
FOXD1 directly represses MICU1 expression in human embryonic stem cells (hESCs) and iPSCs; experimentally restoring MICU1 establishes periodic cytoplasmic Ca2+ oscillations and promotes cellular differentiation and maturation, linking MICU1-mediated mitochondrial Ca2+ dynamics to developmental cell differentiation. |
ChIP, MICU1 overexpression in hESCs/iPSCs, Ca2+ imaging, differentiation marker analysis |
Nature communications |
Medium |
30158529
|
| 2024 |
MICU1 is present in a complex with MCU in non-failing human hearts; MICU1 deletion in murine cardiomyocytes alters mitochondrial Ca2+ signaling and energy metabolism, and causes compensatory increase in EMRE turnover (early) and MCU turnover (later) that limits mitochondrial Ca2+ uptake and supports cell survival. |
Co-immunoprecipitation (human heart tissue), cardiac-specific KO mouse, Ca2+ imaging, metabolic measurement, protein turnover analysis |
PNAS |
High |
39163336
|
| 2025 |
TMBIM5 (mitochondrial Ca2+/proton exchanger) and MICU1 physically coexist in the same macromolecular complex and have opposing effects on submitochondrial localization; partial MICU1 depletion ameliorates Tmbim5-deficiency phenotype in Drosophila, and MICU1 rescues morphological defects in TMBIM5-KO human mitochondria, establishing a functional interplay between TMBIM5 and MICU1. |
Co-immunoprecipitation, Drosophila genetics (epistasis), MICU1 rescue in TMBIM5 KO cells, mitochondrial morphology imaging |
Communications biology |
Medium |
40973741
|
| 2022 |
The splicing factor RBFOX2 drives alternative splicing of MICU1 during myogenesis; human skeletal muscle expresses MICU1 splice variants with distinct abilities to regulate mitochondrial Ca2+ uptake. A muscle-specific splice variant (MICU1.1) confers unique properties ensuring sufficient ATP for muscle contraction. |
RT-PCR splice variant analysis, RBFOX2 knockdown during myogenic differentiation, mitochondrial Ca2+ uptake assay with splice variants |
International journal of molecular sciences |
Medium |
35269658
|
| 2025 |
SIRT1 directly interacts with MICU1; SIRT1 inhibition reduces MICU1 expression, leading to mitochondrial Ca2+ overload and mitochondrial structural fragmentation. |
Co-immunoprecipitation, SIRT1 pharmacological inhibition (EX527) and shRNA knockdown, mitochondrial Ca2+ measurement, mitochondrial morphology imaging |
Life (Basel) |
Low |
40003583
|